Type Public Industry Food industry Operating income Headquarters United Kingdom Number of employees 10 | Traded as LSE: PXS Revenue £ unknown Net income £Unknown Founded 1999 | |
 | ||
Stock price PXS (LON) 0.54 GBX +0.01 (+2.38%)28 Mar, 4:28 PM GMT+1 - Disclaimer Subsidiaries Provexis Ibd Limited, Provexis Natural Products Limited, Provexis Nutrition Ltd. | ||
Provexis PLC is a company established in 1999 to bring the tomato extract "FruitFlow" to the market. The "FruitFlow" product has been approved by the European Food Safety Authority as having a positive effect in the prevention of blood platelet aggregation. It was discovered by Professor Asim Duttaroy ten years ago when he was working at the Rowett Institute of Nutrition and Health of Aberdeen University. He is now working at the Faculty of Medicine, University of Oslo, Norway. He was searching for an effective anti-clotting chemical in plants, so he 'bought every type of fruit and vegetable in Aberdeen and tested them. The company has 75% ownership of NSP#3G, a potential treatment for Crohn's disease, with Liverpool University as the research partner. The company is also researching a potential peptic ulcer treatment in a venture with Manchester University.
Since 2008, the largest shareholder in Provexis PLC is DSM Venturing, with a 30% holding. Barclays hold 8%.
Provexis is the owner of the fruit juice brand Sirco. The juice contains the "FruitFlow" tomato extract and is currently available to buy in the United Kingdom.